Parkinson and Alzheimer two chronic and neurodegenerative diseases that are often associated because they usually strike in old age. While Alzheimer’s affects the memory and cognitive functions of the brain, Parkinson’s involves the functions that control balance and movement. There is currently no cure for these forms of neurodegenerative diseases, only treatments that can be pharmacological and rehabilitative. Nor are there any formulas to follow to prevent them, other than physical activity and a healthy diet. As advised in the article “This is the best drink that keeps the brain young against Parkinson’s”. It is also always recommended to keep the brain active.
But research is making progress every day and what can help in advance, as with all diseases, is early diagnosis. As recommended in the article “A new control to combat memory loss and anticipate Alzheimer’s”. Today the consultants of ProiezionidiBorsa will illustrate how extraordinary these drugs can be that protect the brain from Parkinson’s and Alzheimer’s. Numerous studies have shown that N-Acetylcysteine has antioxidant capacity and is an anti-apoptotic agent, capable of preserving the integrity of neurons and protecting memory.
Extraordinary these drugs that protect the brain from Parkinson’s and Alzheimer’s
N-Acetylcysteine, which is a compound of acetylated cysteine, is known as a remedy for paracetamol overdose. But scientific studies in recent years are rediscovering this compound particularly useful in therapies to counter neurodegenerative diseases. The effects found in various scientific studies make this drug an excellent promise for the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. In fact, it has been found that this compound is able to regulate some important neurotransmitters, such as glutamate which plays a fundamental role in the nervous system. That is, it regulates motor perception and memory.
A very recent study also highlighted how antioxidants protect the brain from inflammation caused by Alzheimer’s and Parkinson’s. In particular, it has been shown that the administration of a drug derived from the drug N-Acetylcysteine reacts to high levels of inflammation deriving from neurodegenerative diseases. This was the first test of the N-acetylcysteine amide compound with stem cells, which opens up new avenues for the treatment of Alzheimer’s and Parkinson’s.
(We remind you to carefully read the warnings regarding this article, which can be consulted who”)